Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


3 Am J Cardiol
4 Cardiovasc Res
2 Circ Cardiovasc Imaging
2 Circ Res
3 Circulation
4 Int J Cardiol
1 J Am Coll Cardiol
2 J Card Fail
1 J Cardiol
1 J Cardiovasc Pharmacol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. BUTTAR C, Lakhdar S, Nso N, Guzman-Perez L, et al
    Meta-Analysis Comparing Outcomes of Remote Hemodynamic Assessment Versus Standard Care in Patients With Heart Failure.
    Am J Cardiol. 2023;192:79-87.
    PubMed         Abstract available

  2. MADNAWAT H, Atallah I, Ahmad A, Harjai K, et al
    Biventricular Noncompaction Cardiomyopathy in a Patient Presenting With a New Cerebrovascular Event.
    Am J Cardiol. 2023;190:110-112.
    PubMed         Abstract available

  3. INGALLINA G, Rampa L, Dicandia M, Boccellino A, et al
    Anesthesia-Induced Intraprocedural Downgrading of Mitral Regurgitation During Transcatheter Edge-to-Edge Repair.
    Am J Cardiol. 2022;190:25-31.
    PubMed         Abstract available

    Cardiovasc Res

  4. Corrigendum to: Global burden of heart failure: a comprehensive and updated review of epidemiology.
    Cardiovasc Res. 2023 Feb 9:cvad026. doi: 10.1093.

  5. CAPONE F, Sotomayor-Flores C, Bode D, Wang R, et al
    Cardiac metabolism in HFpEF: from fuel to signalling.
    Cardiovasc Res. 2023;118:3556-3575.
    PubMed         Abstract available

  6. PORCARI A, Fontana M, Gillmore JD
    Transthyretin cardiac amyloidosis.
    Cardiovasc Res. 2023;118:3517-3535.
    PubMed         Abstract available

  7. DULCE RA, Kanashiro-Takeuchi RM, Takeuchi LM, Salerno AG, et al
    Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
    Cardiovasc Res. 2023;118:3586-3601.
    PubMed         Abstract available

    Circ Cardiovasc Imaging

  8. CARLUCCIO E, Cameli M, Rossi A, Dini FL, et al
    Left Atrial Strain in the Assessment of Diastolic Function in Heart Failure: A Machine Learning Approach.
    Circ Cardiovasc Imaging. 2023 Feb 8:e014605. doi: 10.1161/CIRCIMAGING.122.014605
    PubMed         Abstract available

  9. SANNINO A, Delgado V
    Left Atrial Reservoir Strain and Machine Learning: Augmenting Clinical Care in Heart Failure Patients.
    Circ Cardiovasc Imaging. 2023 Feb 8:e15154. doi: 10.1161/CIRCIMAGING.123.015154.

    Circ Res

  10. SAWICKI KT, De Jesus A, Ardehali H
    Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.
    Circ Res. 2023;132:379-396.
    PubMed         Abstract available

  11. PI H, Xia L, Ralph DD, Rayner SG, et al
    Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
    Circ Res. 2023;132:254-266.
    PubMed         Abstract available


  12. SCHULZE PC, Bogoviku J, Westphal J, Aftanski P, et al
    Response by Schulze et al to Letter Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".
    Circulation. 2023;147:e75.

  13. CAPONE F, Vettor R, Schiattarella GG
    Cardiometabolic HFpEF: NASH of the Heart.
    Circulation. 2023;147:451-453.

  14. SAWAMI K, Tanaka A, Node K
    Letter by Sawami et al Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".
    Circulation. 2023;147:e73-e74.

    Int J Cardiol

  15. KOSTANJSEK L, Ardissino M, Moussa O, Rayes B, et al
    Effect of bariatric surgery on the incidence of heart failure: A propensity score matched nationwide cohort study.
    Int J Cardiol. 2023 Feb 2:S0167-5273(23)00169.
    PubMed         Abstract available

  16. NGUYEN BN, Mital S, Bugden S, Nguyen HV, et al
    Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00120.
    PubMed         Abstract available

  17. ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
    Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Int J Cardiol. 2023;374:65-72.
    PubMed         Abstract available

  18. LIU Y, Li Y, Zhang J, Zhao Y, et al
    Pregnancy outcomes of women with Eisenmenger syndrome: A single-center study.
    Int J Cardiol. 2023;374:35-41.
    PubMed         Abstract available

    J Am Coll Cardiol

  19. KOSIBOROD MN, Bhatt AS, Claggett BL, Vaduganathan M, et al
    Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023;81:460-473.
    PubMed         Abstract available

    J Card Fail

  20. BERNHARDT AM, Copeland H, Deswal A, Gluck J, et al
    The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support.
    J Card Fail. 2023 Feb 2:S1071-9164(22)01185.

  21. SEPEHRVAND N, Nabipoor M, Youngson E, McAlister FA, et al
    Time to triple therapy in patients with de novo heart failure with reduced ejection fraction: a population-based study.
    J Card Fail. 2023 Feb 6:S1071-9164(23)00034.
    PubMed         Abstract available

    J Cardiol

  22. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  23. ZHENG S, Zhang Y, Gu L, Ma K, et al
    Renal Safety of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2023;81:93-103.
    PubMed         Abstract available

    PLoS One

  24. ALCOBERRO L, Moliner P, Vime J, Jimenez-Marrero S, et al
    Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure.
    PLoS One. 2023;18:e0279815.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.